SCHEMBL9534319

SCHEMBL9534319

CC(C)(C)[C](Cc1ccccc1)c1cccc(Cc2ccccc2)c1C(C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.42
CYP2D6 P10635 3/20 0.42
CYP2C19 P33261 3/20 0.42
CYP3A4 P08684 2/20 0.42
GAA P10253 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
BCL2 P10415 1/20 0.35
BCL2L1 Q07817 1/20 0.35
PTPN1 P18031 2/20 0.35
CAPN1 P07384 1/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
HDAC8 Q9BY41 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
CYP1A2 P05177 2/20 0.34
CYP2C9 P11712 2/20 0.34
HTR2A P28223 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7446846 0.78 TSHR (0.39) TSHRCYP2D6CYP2C19CYP3A4GAA
SCHEMBL7444181 0.77 TSHR (0.38) TSHRCYP2D6CYP2C19CYP3A4GAA
SCHEMBL27491083 0.74 BCL2 (0.50) TSHRCYP3A4BCL2BCL2L1MEN1
SCHEMBL7438371 0.71 TSHR (0.38) TSHRCYP2D6CYP2C19CYP3A4BCL2
SCHEMBL9446224 0.70 HRH1 (0.44) TSHRCYP3A4SMN1; SMN2CYP1A2CYP2C9
SCHEMBL2799335 0.68 BCL2 (0.50) CYP3A4BCL2BCL2L1MEN1KMT2A
SCHEMBL17479950 0.68 TSHR (0.53) TSHRCYP2D6CYP2C19CYP3A4PTPN1
SCHEMBL28436811 0.68 HTR2A (0.36) TSHRCYP2D6CYP2C19CYP3A4BCL2
SCHEMBL28389637 0.67 TSHR (0.44) TSHRCYP2D6CYP2C19CYP3A4PTPN1
SCHEMBL9514064 0.65 CA2 (0.55) TSHRBCL2BCL2L1ALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0532693-A1 1,4-DIAMINO-2,3-DIHYDROXYBUTANES THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1993-03-24 EP disclosed